131 related articles for article (PubMed ID: 2557568)
1. Ligand-binding characteristics of [3H]QNB, [3H]prazosin, [3H]rauwolscine, [3H]TCP and [3H]nitrendipine to cerebral cortical and hippocampal membranes of senescence accelerated mouse.
Kitamura Y; Zhao XH; Ohnuki T; Nomura Y
Neurosci Lett; 1989 Dec; 106(3):334-8. PubMed ID: 2557568
[TBL] [Abstract][Full Text] [Related]
2. Effects of deoxyribonuclease I and neuraminidase treatments on the specific binding of 3H-prazosin and 3H-quinuclidinyl benzilate (3H-QNB) to alpha-adrenergic and muscarinic receptors in rat myocardial membranes.
Nagatomo T; Tsuchihashi H; Imai S
Jpn J Pharmacol; 1986 May; 41(1):135-8. PubMed ID: 3016391
[TBL] [Abstract][Full Text] [Related]
3. Lack of specific (3H) prazosin binding sites in dog and rabbit cerebral arteries.
Ferron PM; Banner W; Duckles SP
Life Sci; 1984 Nov; 35(21):2169-76. PubMed ID: 6092817
[TBL] [Abstract][Full Text] [Related]
4. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
7. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
8. Interaction of metals with muscarinic cholinoceptor and adrenoceptor binding, and agonist-stimulated inositol phospholipid hydrolysis in rat brain.
Rajanna B; Chetty CS; Rajanna S; Hall E; Fail S; Yallapragada PR
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Feb; 116(2):111-6. PubMed ID: 9134697
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcium antagonists on muscarinic receptor subtypes in the rat brain.
Katayama S; Kito S; Miyoshi R; Matsubayashi H
Brain Res; 1987 Sep; 422(1):168-71. PubMed ID: 3676778
[TBL] [Abstract][Full Text] [Related]
10. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
11. Computer-assisted image analysis to quantify regional and specific receptor ligand binding: upregulation of [3H]QNB and [3H]WB4101 binding in denervated hippocampus.
Tayrien MW; Loy R
Brain Res Bull; 1984 Dec; 13(6):743-50. PubMed ID: 6152403
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic acetylcholine receptors in bulk-isolated astrocytes of the hippocampus in the rat.
Ułas J
Acta Neurobiol Exp (Wars); 1988; 48(1):41-8. PubMed ID: 3407450
[TBL] [Abstract][Full Text] [Related]
13. Effects of bifemelane hydrochloride, a brain function improver, on muscarinic receptors in the CNS of senescence-accelerated mouse.
Kitamura Y; Ohnuki T; Nomura Y
Jpn J Pharmacol; 1991 Jun; 56(2):231-5. PubMed ID: 1881003
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neurotransmitter receptors in the rat hippocampal formation.
Dooley DJ; Bittiger H
J Neurochem; 1982 Jun; 38(6):1621-6. PubMed ID: 6122720
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
Aguilar JS; Salas PJ; De Robertis E
Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
[No Abstract] [Full Text] [Related]
16. Autoradiographic localization of alpha-adrenoceptors, muscarinic acetylcholine receptors and opiate receptors in the heart.
Dashwood MR; Spyer KM
Eur J Pharmacol; 1986 Aug; 127(3):279-82. PubMed ID: 3019733
[TBL] [Abstract][Full Text] [Related]
17. Developmental changes in beta-adrenoceptors, muscarinic cholinoceptors and Ca2+ channels in rat ventricular muscles.
Kojima M; Ishima T; Taniguchi N; Kimura K; Sada H; Sperelakis N
Br J Pharmacol; 1990 Feb; 99(2):334-9. PubMed ID: 2158375
[TBL] [Abstract][Full Text] [Related]
18. Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium.
Karliner JS; Motulsky HJ; Dunlap J; Brown JH; Insel PA
J Cardiovasc Pharmacol; 1982; 4(3):515-20. PubMed ID: 6177951
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic cholinergic receptors in human foetal brain: characterization and ontogeny of [3H]quinuclidinyl benzilate binding sites in frontal cortex.
Ravikumar BV; Sastry PS
J Neurochem; 1985 Jan; 44(1):240-6. PubMed ID: 3964831
[TBL] [Abstract][Full Text] [Related]
20. Ligand binding characteristics of [3H] dihydroalprenolol in cerebral cortical membranes of young and old senescence-accelerated mouse.
Suh YH; Lee IS; Kim SS; Choi W; Park CW; Chung MH; Lim JK
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Mar; 104(3):423-6. PubMed ID: 8103434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
